Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000653EBVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30013028HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30078106HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055932HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055933HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055934HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055935HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055936HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055937HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055938HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TCGA Plot Options
Drug Information
GenePPARA
DrugBank IDDB01708
Drug NamePrasterone
Target IDBE0000071
UniProt IDQ07869
Regulation Typeactivator
PubMed IDs17591676; 18079279
CitationsKohalmy K, Tamasi V, Kobori L, Sarvary E, Pascussi JM, Porrogi P, Rozman D, Prough RA, Meyer UA, Monostory K: Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metab Dispos. 2007 Sep;35(9):1495-501. Epub 2007 Jun 25.@@Tamasi V, Miller KK, Ripp SL, Vila E, Geoghagen TE, Prough RA: Modulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferators. Mol Pharmacol. 2008 Mar;73(3):968-76. Epub 2007 Dec 13.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationAndrogens and derivatives
SMILES[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@]([H])(O)CC[C@]12C
Pathways
PharmGKBPA451993
ChEMBLCHEMBL90593